HIGHLIGHTS
- who: Stéphane Bardet from the Department of Nuclear Medicine and Thyroid Unit, Centre François Baclesse, Caen, France have published the research work: Diagnostic and prognostic value of a 7-panel mutation testing in thyroid nodules with indeterminate cytology: the SWEETMAC study, in the Journal: (JOURNAL)
- what: The aim of this prospective study (ClinicalTrials.gov: NCT01880203) was to evaluate the diagnostic and prognostic value of a 7-panel testing in the aspirates of with indeterminate cytology (IC).
SUMMARY
Improving the characterization of nodules would allow surveillance in patients with likely . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.